http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Preparation of Recycled Polyvinyl Alcohol) (PVA)/Iodine Polarizing Film
Han, Man Ho,Shin, Jae Kyun,Oh, Kyeong Il,Lee, Young Jae,Song, Du Hyun,Chung, Yong Sik,Lee, Yong Rok,Choi, Han Gon,Oh, Tae Hwan,Han, Sung Soo,Noh, Seok Kyun,Lyoo, Won Seok SAGE Publications 2010 POLYMERS AND POLYMER COMPOSITES Vol.18 No.7
Living donor liver transplantation for patients with alcoholic liver disease
Yo-Han Park,Shin Hwang,Chul-Soo Ahn,Ki-Hun Kim,Deok-Bog Moon,Tae-Yong Ha,Gi-Won Song,Dong-Hwan Jung,Gil-Chun Park,Jung-Man Namgoong,Hyung-Woo Park,Chun-Soo Park,Sung-Hwa Kang,Bo-Hyeon Jung,Sung-Gyu Le 한국간담췌외과학회 2013 한국간담췌외과학회지 Vol.17 No.1
Backgrounds/Aims: Since most transplantation studies for alcoholic liver disease (ALD) were performed on deceased donor liver transplantation, little was known following living donor liver transplantation (LDLT). Methods: The clinical outcome of 18 ALD patients who underwent LDLT from Febraury 1997 to December 2004 in a large-volume liver transplantation center was assessed retrospectively. Results: The model for end-stage liver disease score was 23±11, and mean pretransplant abstinence period was 16±13 months, with 14 (77.8%) patients being abstinent for at least 6 months. Graft types were right lobe grafts in 11, left lobe grafts in 2 and dual grafts in 5. Graft to recipient body weight ratio was 0.94±0.16. The relapse rates in patients who did and did not maintain 6 months of abstinence were 7.1% and 50%, respectively (p=0.097). Younger recipient age was a significant risk factor for alcohol relapse (p=0.027). Five recipients with antibody to hepatitis B surface antigen (HBsAg) received core antibody-positive liver graft, but two of them showed positive HBsAg seroconversion. Overall 5-year patient survival rate following LDLT was 87.8%, with a 5-year relapse rate of 16.7%. Conclusions: Pretransplant abstinence for 6 months appears to be benefical for preventing posttransplant relapse. Life-long prophylactic measure should be followed after use of anti-HBc-positive liver grafts regardless of hepatitis B viral marker status of the recipient.